Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor

Journal of Neuroscience Research

Volumn 60, Issue 4, 2000, Pages 511-519

  Watabe, Kazuhiko ^a   Ohashi, T ^b   Sakamoto, T ^a,b   Kawazoe, Y ^a   Takeshima, T ^c   Oyanagi, K ^a   Inoue, K ^b   Eto, Y ^b   Kim, S U ^d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Avulsion; GDNF; Gene therapy; Motor neuron disease; Spinal cord injury

Indexed keywords

CHOLINE ACETYLTRANSFERASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AVULSION INJURY; BRAIN PROTECTION; FETUS; GENE TRANSFER; MALE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; SPINAL CORD MOTONEURON; VIRUS GENE;

EID: 0034657174     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000515)60:4<511::AID-JNR10>3.0.CO;2-I     Document Type: Article

References (51)

1. Baumgartner BJ, Shine HD. 1997. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factors genes confers neuroprotection that exceeds the transduced population. J Neurosci 17: 6504-6511.
2. Baumgartner BJ, Shine HD. 1998. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp Neurol 153:102-112.
3. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. 1995. Mesencephalic dopaminergic neurons protected by GNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341.
4. Bilang-Bleuel A, Revah F, Colin P, Locquet I, Robert J-J, Mallet J, Horellou P. 1997. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci USA 94:8818-8823.
5. Bohn MC. 1998. A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy. Biochem Pharmacol 57:135-142.
6. Choi-Lundberg DL, Lin Q, Chang Y-N, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. 1997. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838-841.
7. Choi-Lundberg DL, Lin Q, Shallert T, Crippens D, Davidson BL, Chang Y-N, Chiang YF, Qian J, Bardwaj L, Bohn MC. 1998. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp Neurol 154: 261-275.
8. Finiels F, Giménez y Ribotta M, Barkats M, Samolyk M-L, Robert J-J, Privat RA, Revah F, Mallet J. 1995. Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neuron diseases. NeuroReport 7:373-378.
9. Ghadge GD, Roos RP, Kang UJ, Wollmann R, Fishman PS, Kalynych AM, Barr E, Leiden JM. 1995. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 2:132-137.
10. Giménez y Ribotta M, Revah F, Pradier L, Loquet I, Mallet J, Privat A. 1997. Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 48:281-285.
11. Gravel C, Götz R, Lorrain A, Sendtner M. 1997. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nature Med 3:765-770.
12. Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A. 1997. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Med 3:429-436.
13. Haase G, Pettmann B, Vigne E, Castelnau-Ptakhine L, Schmalbruch H, Kahn A. 1998: Adenovirus-mediated gene transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanism of action. J Neurol Sci 160(Suppl 1):S97-S105.
14. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliastos VE, Rosenthal A. 1994. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-1064.
15. Holstege JC, Jongen JLM, Kennis JHH, van Rooyen-Boot AAMA, Vecht CJ. 1998. Immunocytochemical localization of GDNF in primary afferents of the lumbar dorsal horn. NeuroReport 9:2893-2897.
16. Houenou LJ, Oppenheim RW, Li L, Lo AC, Prevette D. 1996. Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res 286:219-223.
17. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis J-C, Hu S, Altrock BW, Fox GM. 1996. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85:1113-1124.
18. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl Acid Res 23:3816-3821.
19. Kishino A, Ishige Y, Tatsuno T, Nakayama C, Noguchi H. 1997. BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth. Exp Neurol 144:273-286.
20. Kojima H, Abiru Y, Sakajiri K, Watabe K, Ohishi N, Takamori M, Hatanaka H, Yagi K. 1997. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain. Biochem Biophys Res Commun 238:564-573.
21. Koliastos VE, Price WL, Pardo CA, Price DL. 1994. Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol 342:35-44.
22. Lapchak PA, Jiao S, Miller PJ, Williams LR, Cummins V, Inouye G, Matheson CR, Yan Q. 1996. Pharmacological characterization of glial cell line derived neurotrophic factor(GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tissue Res 286:179-189.
23. Lapchak PA, Araujo DM, Hilt DC, Sheng J, Jiao S. 1997. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson disease. Brain Res 777:153-160.
24. Li L, Wu W, Lin L-FH, Lei M, Oppenheim RW, Houenou LJ. 1995. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci USA 92:9771-4775.
25. Li L, Houenou LJ, Wu W, Lei M, Prevette DM, Oppenheim RW. 1998. Characterization of spinal motoneuron degeneration following different types of peripheral nerve injury in neonatal and adult mice. J Comp Neurol 396:158-168.
26. Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
27. Lindsay RM. 1995. Neuron saving schemes. Nature 373:289-290.
28. Lowrie MB, Vrbová G. 1992. Dependence of postnatal motoneurons on their targets: review and hypothesis. Trend Neurosci 15:80-84.
29. Martin LJ, Kaiser A, Price AC. 1999. Motor neuron degeneration after nerve avulsion in adult evolves with oxidative stress and is apoptosis. J Neurobiol 40:185-201.
30. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I. 1996. Efficient generation of recombinant adenovirus using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324.
31. Moreau E, Vilar J, Lelièvre-Pégoier M, Marlet-Bénichou C, Gilbert T. 1998. Regulation of c-ret expression by retinoic acid in rat metanephros: implication in nephron mass control. Am J Physiol 275:F938-945.
32. Munson JB, McMahon SB. 1997. Effects of GDNF on axotomized sensory and motor neurons in adult rats. Eur J Neurosci 9:1126-1129.
33. Novikov L, Novikova L, Kellerth JO. 1997. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience 79:765-774.
34. Ohashi T, Watabe K, Uehara K, Sly WS, Vogler C, Eto Y. 1997. Adenovirus-mediated gene transfer and expression of human β-glucuronidase gene in liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. Proc Natl Acad Sci USA 94:1287-1292.
35. Oppenheim RW, Houenou LJ, Johnson JE, Lin L-F H, Li L, Lo AC, Newsome AL, Prevette DM, Wang S. 1995. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373:344-346.
36. Pollin MM, McHanwell S, Slater CR. 1991. The effect of age on motor neurone death following axotomy in the mouse. Development 112:83-89.
37. Ruan R-S, Leong S-K, Yeoh K-H. 1995. The role of nitric oxide in facial motoneuronal death. Brain Res 698:163-168.
38. Schmalbruch H. 1984. Motoneuron death after sciatic nerve section in newborn rats. J Comp Neurol 224:252-258.
39. Schöler HR, Balling R, Hatzopoulos AK, Suzuki N, Gruss P. 1989. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J 8:2551-2557.
40. Snider WD, Thanedar S. 1989. Target dependence of hypoglossal motor neurons during development and in maturity. J Comp Neurol 279:489-498.
41. Soreide AJ. 1981. Variations in the axon reaction after different types of nerve lesion. Acta Anat 110:173-188.
42. Takeshima T, Johnston, JM, Commissiong JW. 1994. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 14:4769-4779.
43. Takeshima T, Shimoda K, Johnston JM, Commissiong JW. 1996. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons. J Neurosci Meth 67:27-41.
44. Tomac A, Lindqvist E, Lin L-F H, Ogrrn SO, Young D, Hoffer BJ, Olson L. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
45. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. 1996. Characterization of a multicomponent receptor for GDNF. Nature 382:80-83.
46. Vejsada R, Tseng JF, Lindsay RM, Acheson A, Aebischer P, Kato AC. 1998. Synergistic but transient rescue effects of GDNF and GDNF on axotomized neonatal motoneurons. Neuroscience 84:129-139.
47. Watabe K, Fukuda T, Tanaka J, Honda H, Toyohara K, Sakai O. 1995. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J Neurosci Res 41:279-290.
48. Widenfalk J, Nosrat C, Tomac A, Westphal H, Hoffer B, Olson L. 1997. Neurturin and glial cell line-derived neurotrophic factor receptor-β (GDNFR-β), novel proteins related to GDNF and GDNFR-α with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J Neurosci 17:8506-8519.
49. Wu W. 1993. Expression of nitric-oxide synthase (NOS) in injured CNS neurons as shown by NADPH diaphorase histochemistry. Exp Neurol 120:153-159.
50. Yan Q, Matheson C, Lopez OT. 1995. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373:341-344.
51. Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P. 1994. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurons. Neuro Report 6:113-118.